Abstract
Neuropathic pain (NP) is a clinically incurable disease with miscellaneous causes, complicated mechanisms and available therapies show poor curative effect. Some recent studies have indicated that neuroinflammation plays a vital role in the occurrence and promotion of NP and anti-inflammatory therapy has the potential to relieve the pain. During the past decades, mesenchymal stem cells (MSCs) with properties of multipotentiality, low immunogenicity and anti-inflammatory activity have showed excellent therapeutic effects in cell therapy from animal models to clinical application, thus aroused great attention. However there are no reports about the effect of intrathecal human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) on NP which is induced by peripheral nerve injury. Therefore, in this study, intrathecally transplanted HUC-MSCs were utilized to examine the effect on neuropathic pain induced by a rat model with spinal nerve ligation (SNL), so as to explore the possible mechanism of those effects. As shown in the results, the HUC-MSCs transplantation obviously ameliorated SNL-induced mechanical allodynia and thermal hyperalgesia, which was related to the inhibiting process of neuroinflammation, including the suppression of activated astrocytes and microglia, as well as the significant reduction of pro-inflammatory cytokines Interleukin-1β (IL-1β) and Interleukin −17A (IL-17A) and the up-regulation of anti-inflammatory cytokine Interleukin −10 (IL-10). Therefore, through the effect on glial cells, pro-inflammatory and anti-inflammatory cytokine, the targeting intrathecal HUC-MSCs may offer a novel treatment strategy for NP.
Similar content being viewed by others
References
Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, Treede RD (2011) A new definition of neuropathic pain. Pain 152:2204–2205
Gilron I, Jensen TS, Dickenson AH (2013) Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol 12:1084–1095
Attal N, Bouhassira D (2015) Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain 156(Suppl 1):S104–S114
Matsuo H, Uchida K, Nakajima H, Guerrero AR, Watanabe S, Takeura N, Sugita D, Shimada S, Nakatsuka T, Baba H (2014) Early transcutaneous electrical nerve stimulation reduces hyperalgesia and decreases activation of spinal glial cells in mice with neuropathic pain. Pain 155:1888–1901
Gao YJ, Ji RR (2010) Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126:56–68
Yamamoto Y, Terayama R, Kishimoto N, Maruhama K, Mizutani M, Iida S, Sugimoto T (2015) Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain. Neurochem Res 40:1000–1012
Svensson CI, Brodin E (2010) Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets. Mol Interv 10:25–38
Otoshi K, Kikuchi S, Konno S, Sekiguchi M (2010) The reactions of glial cells and endoneurial macrophages in the dorsal root ganglion and their contribution to pain-related behavior after application of nucleus pulposus onto the nerve root in rats. Spine (Phila Pa 1976) 35:264–271
Knaan-Shanzer S (2014) Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application. Stem Cells 32:603–608
Franchi S, Castelli M, Amodeo G, Niada S, Ferrari D, Vescovi A, Brini AT, Panerai AE, Sacerdote P (2014) Adult stem cell as new advanced therapy for experimental neuropathic pain treatment. Biomed Res Int 2014:470983
Fortino VR, Pelaez D, Cheung HS (2013) Concise review: stem cell therapies for neuropathic pain. Stem Cells Transl Med 2:394–399
Siniscalco D, Giordano C, Galderisi U, Luongo L, Alessio N, Di Bernardo G, de Novellis V, Rossi F, Maione S (2010) Human mesenchymal stem cells as novel neuropathic pain tool. J Stem Cells Regen Med 6:127
Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136–143
Quaranta P, Focosi D, Di Iesu M, Cursi C, Zucca A, Curcio M, Lapi S, Boldrini L, Stampacchia G, Paolicchi A, Scatena F, Freer G, Pistello M (2016) Human Wharton’s jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties. CytoTherapy 18:205–218
Soleymaninejadian E, Pramanik K, Samadian E (2012) Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 67:1–8
Petrie AC, Tuan RS (2010) Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today 90:67–74
Musolino PL, Coronel MF, Hokfelt T, Villar MJ (2007) Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction. Neurosci Lett 418:97–101
Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, Maione S (2011) Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci 5:79
Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV (2013) Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14:11692–11712
Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S (2003) Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells 21:50–60
Liu X, Liu H, Xu S, Tang Z, Xia W, Cheng Z, Li W, Jin Y (2016) Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model. Pain 157:103–116
Austin TM, Delpire E (2011) Inhibition of KCC2 in mouse spinal cord neurons leads to hypersensitivity to thermal stimulation. Anesth Analg 113:1509–1515
Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24:115–124
Yao CY, Weng ZL, Zhang JC, Feng T, Lin Y, Yao S (2015) Interleukin-17A acts to maintain neuropathic pain through activation of camkii/creb signaling in spinal neurons. Mol Neurobiol 10:1007
Klass M, Gavrikov V, Drury D, Stewart B, Hunter S, Denson DD, Hord A, Csete M (2007) Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesth Analg 104:944–948
Meirelles LS, Nardi NB (2009) Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci (Landmark Ed) 14:4281–4298
Mesentier-Louro LA, Zaverucha-do-Valle C, Rosado-de-Castro PH, Silva-Junior AJ, Pimentel-Coelho PM, Mendez-Otero R, Santiago MF (2016) Bone marrow-derived cells as a therapeutic approach to optic nerve diseases. Stem Cells Int 2016:5078619
Vaquero J, Zurita M, Oya S, Santos M (2006) Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neuroscilett 398:129–134
Amemori T, Jendelova P, Ruzickova K, Arboleda D, Sykova E (2010) Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. CytoTherapy 12:212–225
Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E (2006) Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 23:1379–1391
Lee KH, Suh-Kim H, Choi JS, Jeun SS, Kim EJ, Kim SS, Yoon DH, Lee BH (2007) Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp (Wars) 67:13–22
Schafer S, Berger JV, Deumens R, Goursaud S, Hanisch UK, Hermans E (2014) Influence of intrathecal delivery of bone marrow-derived mesenchymal stem cells on spinal inflammation and pain hypersensitivity in a rat model of peripheral nerve injury. J Neuroinflammation 11:157
Jeon YJ, Kim J, Cho JH, Chung HM, Chae JI (2016) Comparative analysis of human mesenchymal stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy. J Cell Biochem 117:1112–1125
Yousefifard M, Nasirinezhad F, Shardi MH, Janzadeh A, Hosseini M, Keshavarz M (2016) Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther 7:36
Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI (2010) Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 299:L760–L770
Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P, Chen FF, Jiang XD (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 10:106
Ho MS, Mei SH, Stewart DJ (2015) The Immunomodulatory and therapeutic effects of mesenchymal stromal cells for acute lung injury and sepsis. J Cell Physiol 230:2606–2617
Meirelles LS, Fontes AM, Covas DT, Caplan AI (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419–427
Calvo M, Dawes JM, Bennett DL (2012) The role of the immune system in the generation of neuropathic pain. Lancet Neurol 11:629–642
Taylor AR, Welsh CJ, Young C, Spoor E, Kerwin SC, Griffin JF, Levine GJ, Cohen ND, Levine JM (2014) Cerebrospinal fluid inflammatory cytokines and chemokines in naturally occurring canine spinal cord injury. J Neurotrauma 31:1561–1569
Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapy 7:22–30
Liu H, Dolkas J, Hoang K, Angert M, Chernov AV, Remacle AG, Shiryaev SA, Strongin AY, Nishihara T, Shubayev VI (2015) The alternatively spliced fibronectin CS1 isoform regulates IL-17A levels and mechanical allodynia after peripheral nerve injury. J Neuroinflammation 12:158
Kiguchi N, Kobayashi Y, Kishioka S (2012) Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 12:55–61
Ishikawa T, Miyagi M, Kamoda H, Orita S, Eguchi Y, Arai G, Suzuki M, Sakuma Y, Oikawa Y, Inoue G, Aoki Y, Toyone T, Takahashi K, Ohtori S (2013) Differences between tumor necrosis factor-alpha receptors types 1 and 2 in the modulation of spinal glial cell activation and mechanical allodynia in a rat sciatic nerve injury model. Spine (Phila Pa 1976) 38:11–16
Berger JV, Knaepen L, Janssen SP, Jaken RJ, Marcus MA, Joosten EA, Deumens R (2011) Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev 67:282–310
Sato KL, Johanek LM, Sanada LS, Sluka KA (2014) Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain. Anesth Analg 118:464–472
Ni HD, Yao M, Huang B, Xu LS, Zheng Y, Chu YX, Wang HQ, Liu MJ, Xu SJ, Li HB (2016) Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway. J Neurosci Res 94:50–61
Tenorio G, Kulkarni A, Kerr BJ (2013) Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain. Pain 154:71–81
Siniscalco D, Giordano C, Galderisi U, Luongo L, Alessio N, Di Bernardo G, de Novellis V, Rossi F, Maione S (2010) Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Cell Mol Life Sci 67:655–669
Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, Han JS, Kim KS, Yoon HS, Kim SH (2010) Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neuroscilett 468:190–194
Acknowledgments
Support of this project was provided by Grant 81171274 and 81571075 (to Dr. Xiangdong Chen) from the National Natural Science Foundation of China (Beijing, China).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
We declare that there have been no conflicts of interests.
Rights and permissions
About this article
Cite this article
Chen, C., Chen, F., Yao, C. et al. Intrathecal Injection of Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorates Neuropathic Pain in Rats. Neurochem Res 41, 3250–3260 (2016). https://doi.org/10.1007/s11064-016-2051-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-016-2051-5